Fri, February 16 – 10 Stories of The Day!
16 Feb, 2018 | 00:01h | UTC
News release: Individualized, supportive care key to positive childbirth experience, says WHO (free)
Commentary: Give women more time to give birth, make choices – WHO – Reuters (free)
Commentary: Fecal transplants move into the mainstream to treat difficult infection – STAT (free)
3 – Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: No benefit of sodium bicarbonate or acetylcysteine for prevention of complications after angiography: The PRESERVE trial – 2 Minute Medicine (free) AND Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine – NEJM Resident 360 (free)
“Among patients at high risk for renal complications who were undergoing angiography, there was no benefit of intravenous sodium bicarbonate over intravenous sodium chloride or of oral acetylcysteine over placebo for the prevention of death, need for dialysis, or persistent decline in kidney function at 90 days or for the prevention of contrast-associated acute kidney injury”.
4 – Review: Physical Activity in the Prevention and Treatment of Coronary Artery Disease – Journal of the American Heart Association (free for a limited period)
Editorial: Ultra-processed foods and cancer (free)
Commentaries: ‘Ultra-processed’ foods and cancer: Headlines show the right way, and the wrong way, to frame results from an observational study – HealthNewsReview (free) AND Expert reaction to study looking at highly processed foods and cancer – Science Media Centre (free)
6 – Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism – New England Journal of Medicine (link to abstract – $ for full-text)
Quick Take Video Summary: Edoxaban for Cancer-Associated Venous Thromboembolism (free)
Commentaries: Edoxaban Noninferior to Dalteparin for Cancer-Associated VTE – Physician’s First Watch (free) AND Oral Edoxaban Noninferior to Dalteparin for Cancer-Related Venous Thromboembolism – Cardiology Advisor (free)
Commentaries: Premature mortality in single fathers – The Lancet Public Health (free) AND Single fathers have highest risk of early death – OnMedica (free) AND Single Fathers Are More Likely to Die Early, Study Says – TIME (free)
Commentaries: Congenital heart defects linked to increased risk of dementia – American Heart Association News (free) AND Adult Survivors of Congenital Heart Disease at Increased Risk of Dementia – TCTMD (free)
Commentary: Genetic Risk Score May Best FH Variant for Predicting Early-Onset CAD – Medscape (free registration required)
“Another study suggests CAD will soon be predicted not by 1 gene (like FH) but groups of genes that can be combined into risk scores” (via @drjohnm see Tweet)
10 – Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis – JAMA Cardiology (link to abstract – $ for full-text)
Commentaries: Could NOACs Have a Role for Secondary Prevention After STEMI? – TCTMD (free) AND Meta-Analysis: ACS Type Matters for DOAC Use in Secondary Prevention – MedPage Today (free registration required) AND Adding DOACs Beneficial for STEMI — Not Non-STEMI — But with Bleeding Risk – Physician’s First Watch (free)
“63 STEMI patients would need to receive a DOAC to prevent one cardiovascular event, while 96 would need to be treated to cause one major bleeding event”. (from Physician’s First Watch)